Reported positions
Quarter-end holdings as filed
Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.
Nantahala Capital Management, LLC
A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ · methodology §13F ↗
Period
$2.7B
reported valuesum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away
152
positionsALL retained default holdings for this (filer, period), including NULL-value ones
23
new stakespositions with no comparable holding in the prior quarter (kind new), 2026-03-31
24
exitspositions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record
Position changes — into 2026-03-31
by shares · Δ value · filing link · how changes are classified §Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
ISHARES TR RUSSELL 2000 ETFposition key pos:16595 · issuer key iss:1231 PUT | trim | −$156M | −650,000 | $665M | $508M | 2,700,000 | 2,050,000 | |
HERBALIFE LTD COM SHSposition key pos:18974 · issuer key iss:2529 CALL | trim | −$18.1M | −2,200,000 | $101M | $82.4M | 7,800,000 | 5,600,000 | |
PELOTON INTERACTIVE INC CL A COMposition key pos:19036 · issuer key iss:1691 CALL | add | +$36.9M | +11,438,900 | $40.0M | $77.0M | 6,500,000 | 17,938,900 | |
BANCORP INC DEL COMposition key pos:17788 · issuer key iss:319 | add | +$1.8M | +308,771 | $72.4M | $74.2M | 1,071,685 | 1,380,456 | |
EDWARDS LIFESCIENCES CORP COMposition key pos:17342 · issuer key iss:799 PUT | trim | −$89.4M | −1,000,000 | $153M | $64.1M | 1,800,000 | 800,000 | |
HILTON GRAND VACATIONS INC COMposition key pos:15881 · issuer key iss:1117 | trim | −$10.7M | −47,966 | $69.9M | $59.2M | 1,561,622 | 1,513,656 | |
SOLENO THERAPEUTICS INC COMposition key sid:sec:prov:9c654c0b85e21e330a7ebfd2ced217c7 · issuer key cusip6:834203 | add | −$2.4M | +430,122 | $60.8M | $58.4M | 1,314,002 | 1,744,124 | |
BIOVENTUS INC COM CL Aposition key pos:15912 · issuer key cusip6:09075A | add | +$10.9M | +75,000 | $45.0M | $55.9M | 6,047,403 | 6,122,403 | |
PELOTON INTERACTIVE INC CL A COMposition key pos:19036 · issuer key iss:1691 | add | +$14.9M | +6,067,324 | $36.5M | $51.5M | 5,932,676 | 12,000,000 | |
ESTABLISHMENT LABS HLDGS INC COMposition key sid:sec:prov:7bf59fd7aeffb1ecf2ffdacd97c7e39d · issuer key cusip6:G31249 | trim | −$24.7M | −154,733 | $72.0M | $47.3M | 987,689 | 832,956 | |
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADSposition key pos:15751 · issuer key iss:2120 CALL | trim | −$32.8M | −1,000,000 | $78.0M | $45.2M | 2,500,000 | 1,500,000 | |
UNIQURE NV SHSposition key pos:11923 · issuer key iss:2710 CALL | new | +$42.5M | +2,600,000 | $0 | $42.5M | — | 2,600,000 | |
SPDR SERIES TRUST STATE STREET SPDposition key pos:10981 · issuer key iss:1900 PUT | trim | −$10.5M | −100,000 | $48.8M | $38.3M | 400,000 | 300,000 | |
GOGO INC COMposition key pos:12366 · issuer key iss:1022 | add | +$4.1M | +2,089,387 | $31.7M | $35.7M | 6,792,649 | 8,882,036 | |
AMNEAL PHARMACEUTICALS INC COM STK CL Aposition key pos:13504 · issuer key iss:195 | add | +$4.5M | +396,592 | $30.8M | $35.4M | 2,447,516 | 2,844,108 | |
ANTERIS TECHNOLOGIES GLOBAL COMposition key sid:sec:prov:0d957017a1f6113a5600ce99517cee7f · issuer key cusip6:03675P | add | +$18.1M | +3,000,000 | $12.6M | $30.7M | 2,530,910 | 5,530,910 | |
EVOLUS INC COMposition key sid:sec:prov:3c1bdde45f78766466db92da273259f5 · issuer key cusip6:30052C | add | −$12.5M | +556,208 | $38.7M | $26.2M | 5,820,649 | 6,376,857 | |
TANGO THERAPEUTICS INC COMposition key pos:12388 · issuer key iss:2086 | trim | −$5.5M | −2,322,181 | $31.7M | $26.2M | 3,572,633 | 1,250,452 | |
LB PHARMACEUTICALS INC COM SHSposition key sid:sec:prov:be515631054470e2500985b7cc1d1245 · issuer key cusip6:50180M | add | +$10.9M | +377,894 | $15.0M | $26.0M | 675,000 | 1,052,894 | |
SOLENO THERAPEUTICS INC COMposition key sid:sec:prov:9c654c0b85e21e330a7ebfd2ced217c7 · issuer key cusip6:834203 CALL | add | +$1.9M | +248,000 | $23.2M | $25.1M | 502,000 | 750,000 | |
FOX FACTORY HLDG CORP COMposition key sid:sec:prov:58767af0ab04a1d16925b0d6521be622 · issuer key cusip6:35138V | trim | −$12.9M | −700,000 | $37.4M | $24.5M | 2,188,300 | 1,488,300 | |
MINERALYS THERAPEUTICS INC COMposition key sid:sec:prov:d00159df48fd34cc806ae902a076ba0a · issuer key cusip6:603170 | add | +$20.1M | +782,196 | $4.1M | $24.3M | 113,285 | 895,481 | |
ZEVRA THERAPEUTICS INC COM NEWposition key pos:14231 · issuer key cusip6:488445 | add | +$7.6M | +750,000 | $15.9M | $23.5M | 1,771,936 | 2,521,936 | |
FULCRUM THERAPEUTICS INC COMposition key sid:sec:prov:b66dc0816f9158ee3c706ae6f74ba1a4 · issuer key cusip6:359616 | trim | −$25.2M | −1,243,306 | $48.6M | $23.4M | 4,293,346 | 3,050,040 | |
FOSSIL GROUP INC COMposition key pos:19108 · issuer key iss:955 | add | +$4.2M | +339,665 | $19.0M | $23.3M | 5,064,359 | 5,404,024 | |
ABEONA THERAPEUTICS INC COM NEWposition key sid:sec:prov:714d680633cb6e30dfa6e0d524e9cebd · issuer key cusip6:00289Y | add | −$3.7M | +50,000 | $26.2M | $22.5M | 4,963,052 | 5,013,052 | |
CAMPING WORLD HLDGS INC CL Aposition key pos:14397 · issuer key iss:505 | add | +$12.0M | +2,200,732 | $10.3M | $22.3M | 1,058,542 | 3,259,274 | |
ADC THERAPEUTICS SA SHSposition key sid:sec:prov:8da00f0cae7aab2e87fae6f0ec349fcf · issuer key cusip6:H0036K | add | +$1.7M | +122,000 | $19.3M | $21.0M | 5,475,433 | 5,597,433 | |
TITAN MACHY INC COMposition key sid:sec:prov:5e73d6a68c0e56fe22f7ad2a665046e9 · issuer key cusip6:88830R | add | +$2.6M | +34,000 | $18.4M | $21.0M | 1,220,520 | 1,254,520 | |
HERBALIFE LTD COM SHSposition key pos:18974 · issuer key iss:2529 | add | +$8.6M | +471,796 | $11.4M | $19.9M | 881,857 | 1,353,653 | |
IMAX CORP COMposition key sid:sec:prov:9ad1f37e45baa2c0731276ae62c8a2e0 · issuer key cusip6:45245E | add | +$2.0M | +38,462 | $17.6M | $19.6M | 477,092 | 515,554 | |
VERASTEM INC COM NEWposition key pos:14035 · issuer key cusip6:92337C | add | +$15.4M | +3,122,680 | $3.6M | $19.0M | 462,140 | 3,584,820 | |
BIOCRYST PHARMACEUTICALS INC COMposition key pos:15962 · issuer key iss:374 | add | +$8.3M | +631,020 | $10.6M | $18.9M | 1,356,377 | 1,987,397 | |
RAYONIER ADVANCED MATLS INC COMposition key pos:15664 · issuer key iss:1811 | trim | +$7.1M | −200,000 | $10.6M | $17.7M | 1,800,000 | 1,600,000 | |
GERON CORP COMposition key sid:sec:prov:b6aaf2a1d9a7b3e3e2f1185e3325ec7d · issuer key cusip6:374163 | add | +$4.8M | +2,200,000 | $11.9M | $16.7M | 9,025,000 | 11,225,000 | |
BENITEC BIOPHARMA INC COM NEWposition key pos:13249 · issuer key cusip6:08205P | add | +$1.3M | +400,000 | $14.0M | $15.3M | 1,038,371 | 1,438,371 | |
ABIVAX SA SPONSORED ADSposition key pos:13227 · issuer key iss:50 | trim | −$5.4M | −15,998 | $20.7M | $15.3M | 153,235 | 137,237 | |
INTEGER HLDGS CORP COMposition key pos:13475 · issuer key iss:1194 | add | +$7.1M | +70,000 | $8.0M | $15.1M | 102,000 | 172,000 | |
KEROS THERAPEUTICS INC COMposition key pos:16973 · issuer key cusip6:492327 | add | +$7.7M | +1,000,000 | $7.3M | $15.0M | 360,419 | 1,360,419 | |
JACK IN THE BOX INC COMposition key sid:sec:prov:a1234be9f4c05472b46859487a567845 · issuer key cusip6:466367 | add | −$1.5M | +676,725 | $16.4M | $14.9M | 865,990 | 1,542,715 | |
JEFFERSON CAPITAL INC COMposition key sid:sec:prov:10ce318eae94663949d77deb6ce26e99 · issuer key cusip6:47248R | add | +$1.0M | +150,000 | $13.4M | $14.4M | 600,000 | 750,000 | |
USANA HEALTH SCIENCES INC COMposition key sid:sec:prov:f725b948f7855fa28f1f4867550d763d · issuer key cusip6:90328M | add | +$2.7M | +225,000 | $11.5M | $14.2M | 585,074 | 810,074 | |
VAXCYTE INC COMposition key pos:12513 · issuer key iss:2248 | new | +$13.9M | +238,746 | $0 | $13.9M | — | 238,746 | |
MIMEDX GROUP INC COMposition key sid:sec:prov:0a382138189a7364ab79e2b9f8a61343 · issuer key cusip6:602496 | add | −$2.9M | +980,910 | $16.4M | $13.4M | 2,416,389 | 3,397,299 | |
ASSERTIO HOLDINGS INC COM NEWposition key pos:15470 · issuer key iss:256 | add | +$7.9M | +105,000 | $5.3M | $13.2M | 587,335 | 692,335 | |
FOX FACTORY HLDG CORP COMposition key sid:sec:prov:58767af0ab04a1d16925b0d6521be622 · issuer key cusip6:35138V CALL | new | +$13.2M | +800,000 | $0 | $13.2M | — | 800,000 | |
DISTRIBUTION SOLUTIONS GRP I COMposition key sid:sec:prov:2041243a17beca190ede63d1471459b7 · issuer key cusip6:520776 | add | +$3.9M | +164,581 | $9.0M | $13.0M | 330,000 | 494,581 | |
AGOMAB THERAPEUTICS NV SPONSORED ADSposition key sid:sec:prov:fb9ea7ee3bb27d4ceeeb748915397758 · issuer key cusip6:00860C | new | +$12.9M | +1,200,000 | $0 | $12.9M | — | 1,200,000 | |
HELIX ACQUISITION CORP III USD CL A ORD SHSposition key pos:17288 · issuer key iss:2530 | new | +$12.7M | +1,250,000 | $0 | $12.7M | — | 1,250,000 | |
APYX MEDICAL CORPORATION COMposition key sid:sec:prov:e0d051da1ea4170ba22c4d8fa4aa56a5 · issuer key cusip6:03837C | trim | −$1.2M | −533,787 | $13.9M | $12.7M | 3,974,091 | 3,440,304 | |
SILENCE THERAPEUTICS PLC ADSposition key sid:sec:prov:5c7f5b7b9166fb5eb65582ad9f6aefb9 · issuer key cusip6:82686Q | add | +$1.9M | +604,304 | $9.4M | $11.3M | 1,542,427 | 2,146,731 | |
JANUX THERAPEUTICS INC COMposition key sid:sec:prov:7f79da9ff584753bfd1b9acc24c00236 · issuer key cusip6:47103J | new | +$11.3M | +809,914 | $0 | $11.3M | — | 809,914 | |
MONTE ROSA THERAPEUTICS INC COMposition key sid:sec:prov:3224bd4d4c1e7dd823e99e6304f866c2 · issuer key cusip6:61225M | add | +$9.8M | +594,002 | $909K | $10.7M | 57,991 | 651,993 | |
DUOLINGO INC CL A COMposition key pos:15843 · issuer key iss:770 | new | +$9.9M | +100,000 | $0 | $9.9M | — | 100,000 | |
SOLID BIOSCIENCES INC COM NEWposition key pos:12592 · issuer key iss:2004 | trim | −$654K | −438,258 | $9.0M | $8.4M | 1,603,336 | 1,165,078 | |
VIEMED HEALTHCARE INC COMposition key sid:sec:prov:f6eb914553c8f5c7ae0995997b5c1ebe · issuer key cusip6:92663R | trim | +$1.2M | −48,662 | $6.9M | $8.1M | 932,445 | 883,783 | |
RH COMposition key pos:15630 · issuer key iss:1796 | add | +$1.3M | +20,000 | $6.8M | $8.1M | 37,791 | 57,791 | |
OPUS GENETICS INC COMposition key sid:sec:prov:bb257ab3c32f69680923bbff7b61bc99 · issuer key cusip6:67577R | trim | −$2.0M | −3,100,000 | $9.6M | $7.7M | 4,781,330 | 1,681,330 | |
KORRO BIO INC COMposition key sid:sec:prov:32df3091b0447927d2680841e51efc1f · issuer key cusip6:500946 | add | +$2.7M | +60,036 | $4.8M | $7.5M | 600,000 | 660,036 | |
AMYLYX PHARMACEUTICALS INC COMposition key sid:sec:prov:6456a8a739b1b376bb8de72f440b1279 · issuer key cusip6:03237H | trim | −$2.6M | −300,000 | $10.1M | $7.4M | 835,684 | 535,684 | |
DAMORA THERAPEUTICS INC COM NEWposition key pos:17113 · issuer key iss:983 | new | +$7.2M | +278,000 | $0 | $7.2M | — | 278,000 | |
LEXEO THERAPEUTICS INC COMposition key sid:sec:prov:bd4b862f6cf27f7bbb6f4d26443faaca · issuer key cusip6:52886X | add | −$3.0M | +200,000 | $9.9M | $6.9M | 1,000,000 | 1,200,000 | |
VENU HLDG CORP COMposition key sid:sec:prov:da327468723d84926bd7f462da7a0906 · issuer key cusip6:92333E | new | +$6.8M | +2,046,705 | $0 | $6.8M | — | 2,046,705 | |
BANCORP INC DEL COMposition key pos:17788 · issuer key iss:319 CALL | new | +$6.8M | +125,800 | $0 | $6.8M | — | 125,800 | |
CODEXIS INC COMposition key sid:sec:prov:d8d523c018cbcb69a6d1224c1bc35fa5 · issuer key cusip6:192005 | add | +$218K | +133,444 | $6.5M | $6.7M | 3,990,169 | 4,123,613 | |
FRACTYL HEALTH INC COMposition key sid:sec:prov:b437dd7640bddadbb78d4f92535ca4f3 · issuer key cusip6:35168W | add | −$17.7M | +2,518,079 | $23.9M | $6.1M | 10,846,440 | 13,364,519 | |
ALECTOR INC COMposition key sid:sec:prov:1c7c81831d7de024bffc2474a53ee4b9 · issuer key cusip6:014442 | new | +$6.1M | +2,815,983 | $0 | $6.1M | — | 2,815,983 | |
HAIN CELESTIAL GROUP INC COMposition key sid:sec:prov:10c6c046314cd89d84b53e36c90f0fc1 · issuer key cusip6:405217 | add | −$1.0M | +2,000,000 | $7.0M | $6.0M | 6,528,789 | 8,528,789 | |
DIANTHUS THERAPEUTICS INC COMposition key pos:18462 · issuer key iss:731 | trim | −$9.8M | −307,718 | $15.5M | $5.6M | 375,000 | 67,282 | |
KOSMOS ENERGY LTD COMposition key pos:16350 · issuer key iss:1300 | trim | +$3.0M | −500,000 | $2.1M | $5.1M | 2,344,194 | 1,844,194 | |
ENVOY MEDICAL INC CL Aposition key sid:sec:prov:5f776b8ba7f06b01066e3e2d65d7e58b · issuer key cusip6:29415V | new | +$5.1M | +7,650,000 | $0 | $5.1M | — | 7,650,000 | |
DARIOHEALTH CORP COMposition key sid:sec:prov:38042f95de15ec028f081af7281056c4 · issuer key cusip6:23725P | add | −$1.5M | +47,458 | $6.4M | $4.9M | 563,232 | 610,690 | |
REVOLUTION MEDICINES INC COMposition key pos:15541 · issuer key iss:1842 | new | +$4.9M | +50,000 | $0 | $4.9M | — | 50,000 | |
NOODLES & CO CL A NEWposition key sid:sec:prov:ef88c5b6436fe0bd37465efe72a0b6a2 · issuer key cusip6:65540B | new | +$4.7M | +553,746 | $0 | $4.7M | — | 553,746 | |
ABEONA THERAPEUTICS INC COM NEWposition key sid:sec:prov:714d680633cb6e30dfa6e0d524e9cebd · issuer key cusip6:00289Y CALL | add | +$1.8M | +500,000 | $2.7M | $4.6M | 520,000 | 1,020,000 | |
INHIBIKASE THERAPEUTICS INC COM NEWposition key sid:sec:prov:8cb65945c1d745d32abfa3ce25a4d2e9 · issuer key cusip6:45719W | trim | −$3.5M | −1,227,429 | $8.1M | $4.5M | 3,929,292 | 2,701,863 | |
CAESARS ENTERTAINMENT INC NE COMposition key pos:12012 · issuer key iss:496 | new | +$4.0M | +150,000 | $0 | $4.0M | — | 150,000 | |
FORRESTER RESH INC COMposition key sid:sec:prov:67ec08695c00a7b09dc039d605c8d0f9 · issuer key cusip6:346563 | new | +$3.9M | +694,422 | $0 | $3.9M | — | 694,422 | |
UNIQURE NV SHSposition key pos:11923 · issuer key iss:2710 | trim | −$12.9M | −462,220 | $16.7M | $3.9M | 699,298 | 237,078 | |
CHIME FINL INC COM SHS CL Aposition key pos:11202 · issuer key iss:575 | new | +$3.7M | +200,000 | $0 | $3.7M | — | 200,000 | |
UPSTREAM BIO INC COMposition key sid:sec:prov:1e348df3cde91ba41d5ebeef0c53e107 · issuer key cusip6:91678A | trim | −$9.8M | −94,971 | $13.4M | $3.6M | 494,971 | 400,000 | |
GRACE THERAPEUTICS INC COMposition key sid:sec:prov:932b5ca6a4f954f66550ce503d346a69 · issuer key cusip6:00439U | trim | −$705K | −450,000 | $4.1M | $3.4M | 1,178,203 | 728,203 | |
CG ONCOLOGY INC COMposition key pos:12402 · issuer key iss:558 | trim | −$1.2M | −60,000 | $4.5M | $3.3M | 109,449 | 49,449 | |
XENCOR INC COMposition key sid:sec:prov:bc17a1945987420f684d9107b41fd336 · issuer key cusip6:98401F | add | +$671K | +100,000 | $2.5M | $3.2M | 164,639 | 264,639 | |
TELA BIO INC COMposition key sid:sec:prov:4be2e2fddba5743cc2fd041df06ac458 · issuer key cusip6:872381 | add | −$2.8M | +32,526 | $6.0M | $3.2M | 5,111,588 | 5,144,114 | |
TRAEGER INC COM NEWposition key sid:sec:prov:dcd94c09918e02509053911654b89e98 · issuer key cusip6:89269P | new | +$3.0M | +102,408 | $0 | $3.0M | — | 102,408 | |
IMMUNIC INC COMposition key sid:sec:prov:4629488a5d372449ffa54969c78cc5e4 · issuer key cusip6:4525EP | trim | +$445K | −1,871,915 | $2.3M | $2.8M | 4,378,406 | 2,506,491 | |
RALLYBIO CORP COMposition key pos:18442 · issuer key iss:1802 | new | +$2.7M | +300,635 | $0 | $2.7M | — | 300,635 | |
DISC MEDICINE INC COMposition key pos:13022 · issuer key iss:741 PUT | new | +$2.6M | +41,000 | $0 | $2.6M | — | 41,000 | |
DESTINATION XL GROUP INC COMposition key sid:sec:prov:a61184c815603c05c591daa1d25e216d · issuer key cusip6:25065K | trim | −$2.0M | −363,260 | $4.1M | $2.1M | 4,505,000 | 4,141,740 | |
ENTRADA THERAPEUTICS INC COMposition key pos:11501 · issuer key iss:832 | new | +$2.0M | +159,332 | $0 | $2.0M | — | 159,332 | |
DISC MEDICINE INC COMposition key pos:13022 · issuer key iss:741 | trim | −$8.9M | −107,147 | $10.5M | $1.6M | 132,800 | 25,653 | |
PRECISION OPTICS CORP INC MA COM NEWposition key sid:sec:prov:b640cc91467cb95a7b49da2be739b242 · issuer key cusip6:740294 | new | +$1.2M | +280,000 | $0 | $1.2M | — | 280,000 | |
PEPGEN INC COMposition key pos:15762 · issuer key iss:1699 | trim | −$8.9M | −866,071 | $10.1M | $1.2M | 1,547,229 | 681,158 | |
VYNE THERAPEUTICS INC COMposition key sid:sec:prov:99c071aece25dc9d861cc1d194c6734d · issuer key cusip6:92941V | add | +$615K | +1,000,000 | $580K | $1.2M | 1,000,000 | 2,000,000 | |
CURIS INC COMposition key sid:sec:prov:43402af0bb7d5ee4e56ead406d9fffcb · issuer key cusip6:231269 | new | +$1.1M | +2,000,000 | $0 | $1.1M | — | 2,000,000 | |
| pos:12649 PUT | exit‡e | −$18.6M | −130,300 | $18.6M | $0 | 130,300 | — | |
| pos:16467 | exit‡e | −$207K | −626,191 | $207K | $0 | 626,191 | — | |
ISHARES TR RUSSELL 2000 ETFposition key pos:16595 · issuer key iss:1231 | exit‡e | −$28.8M | −117,159 | $28.8M | $0 | 117,159 | — | |
KEROS THERAPEUTICS INC COMposition key pos:16973 · issuer key cusip6:492327 CALL | exit‡e | −$5.1M | −250,000 | $5.1M | $0 | 250,000 | — |
80 more changes below.
1–100 of 120 changes
Mark-to-market only (no share change) · 56
Positions whose share count is identical in both quarters; the value changed with price, not with a decision.
Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
VIATRIS INC COMposition key pos:16938 · issuer key iss:2270 CALL | no change | +$5.3M | 0 | $62.3M | $67.6M | 5,000,000 | 5,000,000 | |
HILTON GRAND VACATIONS INC COMposition key pos:15881 · issuer key iss:1117 CALL | no change | −$6.1M | 0 | $48.1M | $42.1M | 1,075,000 | 1,075,000 | |
SAVARA INC COMposition key sid:sec:prov:2bc6a25d40cf07124e3a03bdecf4a4df · issuer key cusip6:805111 | no change | −$4.2M | 0 | $44.3M | $40.1M | 7,344,783 | 7,344,783 | |
XTANT MED HLDGS INC COM NEWposition key sid:sec:prov:95bdb2d289eb4e63f93099bdf47ba1c0 · issuer key cusip6:98420P | no change | −$15.5M | 0 | $53.6M | $38.2M | 68,394,000 | 68,394,000 | |
REGENERON PHARMACEUTICALS COMposition key pos:16027 · issuer key iss:1826 CALL | no change | +$30.8K | 0 | $30.9M | $30.9M | 40,000 | 40,000 | |
ETON PHARMACEUTICALS INC COMposition key sid:sec:prov:a6062b7020b087adc81a7c6d38642d39 · issuer key cusip6:29772L | no change | +$9.1M | 0 | $19.9M | $29.0M | 1,175,951 | 1,175,951 | |
RIDENOW GROUP INC COM CL Bposition key sid:sec:prov:4e58f39841181a66430231468b1901db · issuer key cusip6:781386 | no change | +$5.0M | 0 | $18.1M | $23.1M | 3,272,845 | 3,272,845 | |
AVALO THERAPEUTICS INC COM NEWposition key sid:sec:prov:37b91915f07af95197894a79df85a91e · issuer key cusip6:05338F | no change | −$4.0M | 0 | $22.4M | $18.4M | 1,235,000 | 1,235,000 | |
RMR GROUP INC CL Aposition key sid:sec:prov:8be78d3fcfd6865b5cef7c8f60ea07c1 · issuer key cusip6:74967R | no change | +$654K | 0 | $17.1M | $17.8M | 1,147,902 | 1,147,902 | |
ALIGN TECHNOLOGY INC COMposition key pos:14931 · issuer key iss:134 CALL | no change | +$1.5M | 0 | $15.6M | $17.1M | 100,000 | 100,000 | |
AURA BIOSCIENCES INC COMposition key sid:sec:prov:d9ef490e51d912cfdcf16dffb423f2d5 · issuer key cusip6:05153U | no change | +$2.6M | 0 | $11.5M | $14.2M | 2,117,697 | 2,117,697 | |
CAMPING WORLD HLDGS INC CL Aposition key pos:14397 · issuer key iss:505 CALL | no change | −$5.8M | 0 | $19.5M | $13.7M | 2,000,000 | 2,000,000 | |
RIDENOW GROUP INC COM CL Bposition key sid:sec:prov:4e58f39841181a66430231468b1901db · issuer key cusip6:781386 CALL | no change | +$2.6M | 0 | $9.4M | $12.0M | 1,700,000 | 1,700,000 | |
CHIME FINL INC COM SHS CL Aposition key pos:11202 · issuer key iss:575 CALL | no change | −$3.9M | 0 | $15.1M | $11.2M | 600,000 | 600,000 | |
1 800 FLOWERS COM INC CL Aposition key sid:sec:prov:c7b176172dd4b9b47526fcdb3ac99b32 · issuer key cusip6:68243Q | no change | −$3.0M | 0 | $13.3M | $10.3M | 3,375,065 | 3,375,065 | |
CENTESSA PHARMACEUTICALS PLC SPONSORED ADSposition key pos:18882 · issuer key cusip6:152309 | no change | +$3.7M | 0 | $6.4M | $10.1M | 254,803 | 254,803 | |
X4 PHARMACEUTICALS INC COM NEWposition key sid:sec:prov:19b9675407eb505d5af586b26c66f53a · issuer key cusip6:98420X | no change | +$318K | 0 | $9.8M | $10.1M | 2,449,468 | 2,449,468 | |
COGENT BIOSCIENCES INC COMposition key pos:18333 · issuer key iss:610 | no change | +$743K | 0 | $8.9M | $9.6M | 250,000 | 250,000 | |
SERVICE PPTYS TR COM SH BEN INTposition key sid:sec:prov:0e061acc18b30e6b85d995197008e95d · issuer key cusip6:81761L | no change | −$3.4M | 0 | $13.0M | $9.6M | 7,057,887 | 7,057,887 | |
INDUSTRIAL LOGISTICS PPTYS T COM SHS BEN INTposition key sid:sec:prov:dfb41d7d7944de28f579e5e287b65438 · issuer key cusip6:456237 | no change | +$235K | 0 | $9.3M | $9.5M | 1,678,973 | 1,678,973 | |
RESERVOIR MEDIA INC COMposition key sid:sec:prov:44bdc95680105290a0802d9d1ce00f6d · issuer key cusip6:76119X | no change | +$2.1M | 0 | $7.1M | $9.2M | 940,960 | 940,960 | |
TRISALUS LIFE SCIENCES INC COMposition key sid:sec:prov:23294fd27516b3a2a3451405ff978b74 · issuer key cusip6:89680M | no change | −$6.2M | 0 | $14.5M | $8.3M | 2,070,827 | 2,070,827 | |
AMERICAS CAR-MART INC COMposition key sid:sec:prov:8c8a451d523e569b99f369127fe88d89 · issuer key cusip6:03062T | no change | −$8.1M | 0 | $16.3M | $8.2M | 644,686 | 644,686 | |
RH COMposition key pos:15630 · issuer key iss:1796 CALL | no change | −$2.0M | 0 | $9.0M | $7.0M | 50,000 | 50,000 | |
DHI GROUP INC COMposition key sid:sec:prov:e6bcb1b2825c0ca0c35f63dc759381af · issuer key cusip6:23331S | no change | +$3.0M | 0 | $3.7M | $6.7M | 2,374,027 | 2,374,027 | |
UNICYCIVE THERAPEUTICS INC COM NEWposition key sid:sec:prov:dfd0154b493c84f8cf2ed4d228add022 · issuer key cusip6:90466Y | no change | +$761K | 0 | $5.4M | $6.2M | 939,202 | 939,202 | |
INSPIREMD INC COMposition key sid:sec:prov:4f3f0dbc6f010cb94ff5053ef428025c · issuer key cusip6:45779A | no change | −$506K | 0 | $6.0M | $5.5M | 3,376,484 | 3,376,484 | |
ALTA EQUIPMENT GROUP INC COMMON STOCKposition key sid:sec:prov:372f1a35b34d9464ec8bc6bf5479bea3 · issuer key cusip6:02128L | no change | +$720K | 0 | $4.3M | $5.0M | 934,774 | 934,774 | |
MARA HOLDINGS INC NOTE 3/0position key sid:sec:prov:450afa4275cd3ffd3819bf46d2a30872 · issuer key cusip6:565788 PRN | no change | +$490K | 0 | $3.9M | $4.4M | 5,000,000 | 5,000,000 | |
THE ONE GROUP HOSPITALITY IN COMposition key sid:sec:prov:6baeac96f8e53f3a66ba5e4bae818a50 · issuer key cusip6:88338K | no change | +$63.6K | 0 | $3.7M | $3.8M | 2,121,084 | 2,121,084 | |
NN INC COMposition key sid:sec:prov:99861ad80ad0561e428b459394a843de · issuer key cusip6:629337 | no change | +$415K | 0 | $3.1M | $3.5M | 2,441,416 | 2,441,416 | |
ELUTIA INC CL A COMposition key sid:sec:prov:673ef30f5f9511fed45c017b8debd1ec · issuer key cusip6:05479K | no change | +$1.1M | 0 | $2.2M | $3.3M | 3,184,947 | 3,184,947 | |
ARVINAS INC COMposition key pos:12209 · issuer key iss:250 | no change | −$378K | 0 | $3.6M | $3.2M | 300,000 | 300,000 | |
ORTHOPEDIATRICS CORP COMposition key sid:sec:prov:71e6d7a9978be392e4db6948ea1b496a · issuer key cusip6:68752L | no change | −$377K | 0 | $3.5M | $3.2M | 199,449 | 199,449 | |
AYTU BIOPHARMA INC COMposition key sid:sec:prov:fab0b4c43bdd86414df0ec3f291c0c5e · issuer key cusip6:054754 | no change | +$141K | 0 | $2.8M | $3.0M | 1,086,812 | 1,086,812 | |
SCULLY ROYALTY LTD COM SHSposition key sid:sec:prov:66dd1afa2de5cc52231668f4ef938ada · issuer key cusip6:G7T96K | no change | −$269K | 0 | $3.1M | $2.9M | 368,182 | 368,182 | |
AKEBIA THREAPEUTICS INC COMposition key pos:13047 · issuer key iss:109 | no change | −$440K | 0 | $3.2M | $2.8M | 2,000,000 | 2,000,000 | |
TALPHERA INC COM NEWposition key sid:sec:prov:cd566f05fb4580eab7b0f7b37ca1708d · issuer key cusip6:00444T | no change | −$1.4M | 0 | $4.0M | $2.6M | 3,492,519 | 3,492,519 | |
GAIA INC NEW CL Aposition key sid:sec:prov:6508c8ca8a5725368c9374844e6c23d0 · issuer key cusip6:36269P | no change | −$787K | 0 | $3.3M | $2.5M | 914,618 | 914,618 | |
PAYONEER GLOBAL INC COMposition key pos:18697 · issuer key iss:1687 | no change | −$382K | 0 | $2.7M | $2.3M | 483,836 | 483,836 | |
EHEALTH INC COMposition key sid:sec:prov:cc91c1fcc3ed81376bd9bdb3b8d68cbe · issuer key cusip6:28238P | no change | −$5.8M | 0 | $8.1M | $2.3M | 1,761,441 | 1,761,441 | |
READING INTL INC CL Aposition key sid:sec:prov:6b99d71bd850e6ba64b11bba53adda55 · issuer key cusip6:755408 | no change | +$154K | 0 | $2.0M | $2.2M | 1,921,088 | 1,921,088 | |
VAXCYTE INC COMposition key pos:12513 · issuer key iss:2248 CALL | no change | +$421K | 0 | $1.6M | $2.0M | 35,200 | 35,200 | |
BRC INC COM CL Aposition key sid:sec:prov:9e36e5712fa13148f5ef7661cfedc657 · issuer key cusip6:05601U | no change | −$878K | 0 | $2.9M | $2.0M | 2,630,517 | 2,630,517 | |
ACHIEVE LIFE SCIENCE INC COMposition key sid:sec:prov:3404945f22523373b576582309ed1879 · issuer key cusip6:004468 | no change | −$1.3M | 0 | $3.2M | $1.9M | 648,885 | 648,885 | |
PERFECT CORP CL A ORD SHSposition key sid:sec:prov:65d8ca28e9ce6babf2418ef17007d6e7 · issuer key cusip6:G7006A | no change | −$70.1K | 0 | $1.1M | $987K | 583,925 | 583,925 | |
ALTISOURCE PORTFOLIO SOLUTIO *W EXP 04/30/203position key sid:sec:prov:9c731633f4aa2766f20e6a166d82cec4 · issuer key cusip6:L0175J | no change | −$74.6K | 0 | $1.0M | $941K | 2,477,312 | 2,477,312 | |
ACME UTD CORP COMposition key sid:sec:prov:4d48e8479d984a641a8a95d3ff4765d9 · issuer key cusip6:004816 | no change | +$94.0K | 0 | $823K | $917K | 20,427 | 20,427 | |
SENTI BIOSCIENCES INC COM NEWposition key sid:sec:prov:eb9d9bf552e37ae10cf446f3026e3a44 · issuer key cusip6:81726A | no change | −$202K | 0 | $924K | $721K | 888,000 | 888,000 | |
ALTISOURCE PORTFOLIO SOLUTIO *W EXP 04/02/202position key sid:sec:prov:a5909ea231bd52afcd1727c9a9d5a528 · issuer key cusip6:L0175J | no change | −$322K | 0 | $818K | $495K | 2,477,312 | 2,477,312 | |
TELA BIO INC COMposition key sid:sec:prov:4be2e2fddba5743cc2fd041df06ac458 · issuer key cusip6:872381 CALL | no change | −$420K | 0 | $885K | $465K | 750,000 | 750,000 | |
BIOMX INC COM NEWposition key sid:sec:prov:33cefd366aaeacb00c6016055a143d33 · issuer key cusip6:09090D | no change | +$216K | 0 | $215K | $431K | 114,795 | 114,795 | |
SPAR GROUP INC COMposition key sid:sec:prov:5cde732b844f69dafa864b61a10fd907 · issuer key cusip6:784933 | no change | −$119K | 0 | $532K | $413K | 660,688 | 660,688 | |
APREA THERAPEUTICS INC COM NEWposition key sid:sec:prov:f6a724b9b2b95c7dd5f1329c4db8ca1e · issuer key cusip6:03836J | no change | −$18.5K | 0 | $176K | $157K | 205,760 | 205,760 | |
GUARDFORCE AI CO LTD *W EXP 10/01/202position key sid:sec:prov:e64a96ff0ef7de38d68d1b65e84ebd7d · issuer key cusip6:G4236L | no change | −$13.9K | 0 | $23.1K | $9.3K | 154,205 | 154,205 | |
PERFECT CORP *W EXP 10/28/202position key sid:sec:prov:b30710691540378b46a7ae3ecaecdb32 · issuer key cusip6:G7006A | no change | −$85 | 0 | $323 | $238 | 16,075 | 16,075 |
Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
Changes derive from the aggregate's top-25 slices and keyable positions only; unkeyable holdings are counted in the registry, not differenced. methodology §13F ↗
Book shape
2026-03-31 · concentration · vs tracked median · tick = median- Top-25 concentration
- 60.1%below median 80.0%
- Concentration index
- 451 bpsabove median 446 bps
- Positions with value
- 152 / 152median book 97.5 positions
Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.
null-value positions: 0holdings whose <value> did not parse — retained and counted, never zero-filled · top-N share ·§: 60.1% · HHI (bps) ·§: 451integer Herfindahl–Hirschman index in basis points over disclosed position values · QoQ moves: 176
Filing history
AVAILABLE QUARTERS| Period | Source |
|---|---|
| 2026-03-31 | EDGAR ↗ |
PLANNED sector rotation · Congress overlap · signals for this filer
Complete source filings on SEC EDGAR
The complete filing on EDGAR.
The position list above is served from the published Public Filings build — every position this filer reported for the selected quarter, as it reported it. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Serving this list is M2-CONTRACT §3, amended 2026-08-02; §3.1 keeps live EDGAR for filings newer than this build.
Open Nantahala Capital Management, LLC's 13F filings on SEC EDGAR ↗Notes on this data
Share changes
Compare consecutive quarters
Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.
Coverage
A snapshot, not current holdings
Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.
ViewPrior quarter not yet availableThis build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.
Reported positions — 2026-03-31
1–100 of 135 issuers · $2.7B disclosed value over 152 rows · 0 undisclosed-value rowsEvery row below carries ticker not yet mapped — stated once here rather than repeated on every row.
| KindClassification is not joined into this reported-position view. Use the changed-positions view to compare the two published quarters. | TickerThis list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names. | Issuera position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing | WeightShare of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets. | Valuevalue undisclosed on the filing: retained and counted, excluded from sums, never shown as $0 | Shares | Position changeShare change is available in the separate comparison view; it is not joined into this position list. | Wt | CongressThe congressional transaction join is unavailable in this build. |
|---|---|---|---|---|---|---|---|---|
| — | — | ISHARES TR ISHARES TR · RUSSELL 2000 ETF · PUT CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $508M | 2,050,000 | — | 18.7% | — | |
| — | PTONverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PELOTON INTERACTIVE INC | $128M | 29,938,900 | — | 4.7% | — | |
| — | HLFverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HERBALIFE LTD | $102M | 6,953,653 | — | 3.8% | — | |
| — | HGVverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HILTON GRAND VACATIONS INC | $101M | 2,588,656 | — | 3.7% | — | |
| — | — | SOLENO THERAPEUTICS INC | $83.5M | 2,494,124 | — | 3.1% | — | |
| — | TBBKverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BANCORP INC DEL | $80.9M | 1,506,256 | — | 3.0% | — | |
| — | VTRSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VIATRIS INC VIATRIS INC · COM · CALL CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $67.6M | 5,000,000 | — | 2.5% | — | |
| — | EWverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | EDWARDS LIFESCIENCES CORP EDWARDS LIFESCIENCES CORP · COM · PUT CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $64.1M | 800,000 | — | 2.4% | — | |
| — | — | BIOVENTUS INC BIOVENTUS INC · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $55.9M | 6,122,403 | — | 2.1% | — | |
| — | — | ESTABLISHMENT LABS HLDGS INC ESTABLISHMENT LABS HLDGS INC · COM CUSIP G31249108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $47.3M | 832,956 | — | 1.7% | — | |
| — | QUREverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UNIQURE NV | $46.4M | 2,837,078 | — | 1.7% | — | |
| — | TEVAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TEVA PHARMACEUTICAL INDS LTD TEVA PHARMACEUTICAL INDS LTD · SPONSORED ADS · CALL CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $45.2M | 1,500,000 | — | 1.7% | — | |
| — | — | SAVARA INC SAVARA INC · COM CUSIP 805111101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $40.1M | 7,344,783 | — | 1.5% | — | |
| — | — | SPDR SERIES TRUST SPDR SERIES TRUST · STATE STREET SPD · PUT CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $38.3M | 300,000 | — | 1.4% | — | |
| — | — | XTANT MED HLDGS INC XTANT MED HLDGS INC · COM NEW CUSIP 98420P308 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $38.2M | 68,394,000 | — | 1.4% | — | |
| — | — | FOX FACTORY HLDG CORP | $37.7M | 2,288,300 | — | 1.4% | — | |
| — | CWHverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CAMPING WORLD HLDGS INC | $35.9M | 5,259,274 | — | 1.3% | — | |
| — | GOGOverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GOGO INC GOGO INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $35.7M | 8,882,036 | — | 1.3% | — | |
| — | AMRXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AMNEAL PHARMACEUTICALS INC AMNEAL PHARMACEUTICALS INC · COM STK CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $35.4M | 2,844,108 | — | 1.3% | — | |
| — | — | RIDENOW GROUP INC | $35.1M | 4,972,845 | — | 1.3% | — | |
| — | REGNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | REGENERON PHARMACEUTICALS REGENERON PHARMACEUTICALS · COM · CALL CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $30.9M | 40,000 | — | 1.1% | — | |
| — | — | ANTERIS TECHNOLOGIES GLOBAL ANTERIS TECHNOLOGIES GLOBAL · COM CUSIP 03675P102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $30.7M | 5,530,910 | — | 1.1% | — | |
| — | — | ETON PHARMACEUTICALS INC ETON PHARMACEUTICALS INC · COM CUSIP 29772L108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $29.0M | 1,175,951 | — | 1.1% | — | |
| — | — | ABEONA THERAPEUTICS INC | $27.0M | 6,033,052 | — | 1.0% | — | |
| — | — | EVOLUS INC EVOLUS INC · COM CUSIP 30052C107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $26.2M | 6,376,857 | — | 1.0% | — | |
| — | TNGXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TANGO THERAPEUTICS INC TANGO THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $26.2M | 1,250,452 | — | 1.0% | — | |
| — | — | LB PHARMACEUTICALS INC LB PHARMACEUTICALS INC · COM SHS CUSIP 50180M108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $26.0M | 1,052,894 | — | 1.0% | — | |
| — | — | MINERALYS THERAPEUTICS INC MINERALYS THERAPEUTICS INC · COM CUSIP 603170101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.3M | 895,481 | — | 0.9% | — | |
| — | — | ZEVRA THERAPEUTICS INC ZEVRA THERAPEUTICS INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.5M | 2,521,936 | — | 0.9% | — | |
| — | — | FULCRUM THERAPEUTICS INC FULCRUM THERAPEUTICS INC · COM CUSIP 359616109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.4M | 3,050,040 | — | 0.9% | — | |
| — | FOSLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FOSSIL GROUP INC FOSSIL GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.3M | 5,404,024 | — | 0.9% | — | |
| — | — | ADC THERAPEUTICS SA ADC THERAPEUTICS SA · SHS CUSIP H0036K147 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $21.0M | 5,597,433 | — | 0.8% | — | |
| — | — | TITAN MACHY INC TITAN MACHY INC · COM CUSIP 88830R101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $21.0M | 1,254,520 | — | 0.8% | — | |
| — | — | IMAX CORP IMAX CORP · COM CUSIP 45245E109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $19.6M | 515,554 | — | 0.7% | — | |
| — | — | VERASTEM INC VERASTEM INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $19.0M | 3,584,820 | — | 0.7% | — | |
| — | BCRXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BIOCRYST PHARMACEUTICALS INC BIOCRYST PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $18.9M | 1,987,397 | — | 0.7% | — | |
| — | — | AVALO THERAPEUTICS INC AVALO THERAPEUTICS INC · COM NEW CUSIP 05338F306 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $18.4M | 1,235,000 | — | 0.7% | — | |
| — | — | RMR GROUP INC RMR GROUP INC · CL A CUSIP 74967R106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $17.8M | 1,147,902 | — | 0.7% | — | |
| — | RYAMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | RAYONIER ADVANCED MATLS INC RAYONIER ADVANCED MATLS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $17.7M | 1,600,000 | — | 0.7% | — | |
| — | ALGNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ALIGN TECHNOLOGY INC ALIGN TECHNOLOGY INC · COM · CALL CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $17.1M | 100,000 | — | 0.6% | — | |
| — | — | GERON CORP GERON CORP · COM CUSIP 374163103 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $16.7M | 11,225,000 | — | 0.6% | — | |
| — | PCVXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VAXCYTE INC | $15.9M | 273,946 | — | 0.6% | — | |
| — | — | BENITEC BIOPHARMA INC BENITEC BIOPHARMA INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $15.3M | 1,438,371 | — | 0.6% | — | |
| — | ABVXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ABIVAX SA ABIVAX SA · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $15.3M | 137,237 | — | 0.6% | — | |
| — | ITGRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INTEGER HLDGS CORP INTEGER HLDGS CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $15.1M | 172,000 | — | 0.6% | — | |
| — | RHverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | RH | $15.1M | 107,791 | — | 0.6% | — | |
| — | — | KEROS THERAPEUTICS INC KEROS THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $15.0M | 1,360,419 | — | 0.6% | — | |
| — | CHYMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CHIME FINL INC | $15.0M | 800,000 | — | 0.6% | — | |
| — | — | JACK IN THE BOX INC JACK IN THE BOX INC · COM CUSIP 466367109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $14.9M | 1,542,715 | — | 0.5% | — | |
| — | — | JEFFERSON CAPITAL INC JEFFERSON CAPITAL INC · COM CUSIP 47248R103 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $14.4M | 750,000 | — | 0.5% | — | |
| — | — | AURA BIOSCIENCES INC AURA BIOSCIENCES INC · COM CUSIP 05153U107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $14.2M | 2,117,697 | — | 0.5% | — | |
| — | — | USANA HEALTH SCIENCES INC USANA HEALTH SCIENCES INC · COM CUSIP 90328M107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $14.2M | 810,074 | — | 0.5% | — | |
| — | — | MIMEDX GROUP INC MIMEDX GROUP INC · COM CUSIP 602496101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $13.4M | 3,397,299 | — | 0.5% | — | |
| — | — | ASSERTIO HOLDINGS INC ASSERTIO HOLDINGS INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $13.2M | 692,335 | — | 0.5% | — | |
| — | — | DISTRIBUTION SOLUTIONS GRP I DISTRIBUTION SOLUTIONS GRP I · COM CUSIP 520776105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $13.0M | 494,581 | — | 0.5% | — | |
| — | — | AGOMAB THERAPEUTICS NV AGOMAB THERAPEUTICS NV · SPONSORED ADS CUSIP 00860C102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $12.9M | 1,200,000 | — | 0.5% | — | |
| — | HLXCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HELIX ACQUISITION CORP III HELIX ACQUISITION CORP III · USD CL A ORD SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $12.7M | 1,250,000 | — | 0.5% | — | |
| — | — | APYX MEDICAL CORPORATION APYX MEDICAL CORPORATION · COM CUSIP 03837C106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $12.7M | 3,440,304 | — | 0.5% | — | |
| — | — | SILENCE THERAPEUTICS PLC SILENCE THERAPEUTICS PLC · ADS CUSIP 82686Q101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $11.3M | 2,146,731 | — | 0.4% | — | |
| — | — | JANUX THERAPEUTICS INC JANUX THERAPEUTICS INC · COM CUSIP 47103J105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $11.3M | 809,914 | — | 0.4% | — | |
| — | — | MONTE ROSA THERAPEUTICS INC MONTE ROSA THERAPEUTICS INC · COM CUSIP 61225M102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $10.7M | 651,993 | — | 0.4% | — | |
| — | — | 1 800 FLOWERS COM INC 1 800 FLOWERS COM INC · CL A CUSIP 68243Q106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $10.3M | 3,375,065 | — | 0.4% | — | |
| — | — | CENTESSA PHARMACEUTICALS PLC CENTESSA PHARMACEUTICALS PLC · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $10.1M | 254,803 | — | 0.4% | — | |
| — | — | X4 PHARMACEUTICALS INC X4 PHARMACEUTICALS INC · COM NEW CUSIP 98420X202 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $10.1M | 2,449,468 | — | 0.4% | — | |
| — | DUOLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DUOLINGO INC DUOLINGO INC · CL A COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.9M | 100,000 | — | 0.4% | — | |
| — | COGTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | COGENT BIOSCIENCES INC COGENT BIOSCIENCES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.6M | 250,000 | — | 0.4% | — | |
| — | — | SERVICE PPTYS TR SERVICE PPTYS TR · COM SH BEN INT CUSIP 81761L102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.6M | 7,057,887 | — | 0.4% | — | |
| — | — | INDUSTRIAL LOGISTICS PPTYS T INDUSTRIAL LOGISTICS PPTYS T · COM SHS BEN INT CUSIP 456237106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.5M | 1,678,973 | — | 0.4% | — | |
| — | — | RESERVOIR MEDIA INC RESERVOIR MEDIA INC · COM CUSIP 76119X105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.2M | 940,960 | — | 0.3% | — | |
| — | SLDBverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SOLID BIOSCIENCES INC SOLID BIOSCIENCES INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $8.4M | 1,165,078 | — | 0.3% | — | |
| — | — | TRISALUS LIFE SCIENCES INC TRISALUS LIFE SCIENCES INC · COM CUSIP 89680M101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $8.3M | 2,070,827 | — | 0.3% | — | |
| — | — | AMERICAS CAR-MART INC AMERICAS CAR-MART INC · COM CUSIP 03062T105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $8.2M | 644,686 | — | 0.3% | — | |
| — | — | VIEMED HEALTHCARE INC VIEMED HEALTHCARE INC · COM CUSIP 92663R105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $8.1M | 883,783 | — | 0.3% | — | |
| — | — | OPUS GENETICS INC OPUS GENETICS INC · COM CUSIP 67577R102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $7.7M | 1,681,330 | — | 0.3% | — | |
| — | — | KORRO BIO INC KORRO BIO INC · COM CUSIP 500946108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $7.5M | 660,036 | — | 0.3% | — | |
| — | — | AMYLYX PHARMACEUTICALS INC AMYLYX PHARMACEUTICALS INC · COM CUSIP 03237H101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $7.4M | 535,684 | — | 0.3% | — | |
| — | DMRAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DAMORA THERAPEUTICS INC DAMORA THERAPEUTICS INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $7.2M | 278,000 | — | 0.3% | — | |
| — | — | LEXEO THERAPEUTICS INC LEXEO THERAPEUTICS INC · COM CUSIP 52886X107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $6.9M | 1,200,000 | — | 0.3% | — | |
| — | — | VENU HLDG CORP VENU HLDG CORP · COM CUSIP 92333E104 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $6.8M | 2,046,705 | — | 0.2% | — | |
| — | — | CODEXIS INC CODEXIS INC · COM CUSIP 192005106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $6.7M | 4,123,613 | — | 0.2% | — | |
| — | — | DHI GROUP INC DHI GROUP INC · COM CUSIP 23331S100 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $6.7M | 2,374,027 | — | 0.2% | — | |
| — | — | UNICYCIVE THERAPEUTICS INC UNICYCIVE THERAPEUTICS INC · COM NEW CUSIP 90466Y202 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $6.2M | 939,202 | — | 0.2% | — | |
| — | — | FRACTYL HEALTH INC FRACTYL HEALTH INC · COM CUSIP 35168W103 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $6.1M | 13,364,519 | — | 0.2% | — | |
| — | — | ALECTOR INC ALECTOR INC · COM CUSIP 014442107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $6.1M | 2,815,983 | — | 0.2% | — | |
| — | — | HAIN CELESTIAL GROUP INC HAIN CELESTIAL GROUP INC · COM CUSIP 405217100 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $6.0M | 8,528,789 | — | 0.2% | — | |
| — | DNTHverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DIANTHUS THERAPEUTICS INC DIANTHUS THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $5.6M | 67,282 | — | 0.2% | — | |
| — | — | INSPIREMD INC INSPIREMD INC · COM CUSIP 45779A846 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $5.5M | 3,376,484 | — | 0.2% | — | |
| — | KOSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | KOSMOS ENERGY LTD KOSMOS ENERGY LTD · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $5.1M | 1,844,194 | — | 0.2% | — | |
| — | — | ENVOY MEDICAL INC ENVOY MEDICAL INC · CL A CUSIP 29415V109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $5.1M | 7,650,000 | — | 0.2% | — | |
| — | — | ALTA EQUIPMENT GROUP INC ALTA EQUIPMENT GROUP INC · COMMON STOCK CUSIP 02128L106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $5.0M | 934,774 | — | 0.2% | — | |
| — | — | DARIOHEALTH CORP DARIOHEALTH CORP · COM CUSIP 23725P308 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $4.9M | 610,690 | — | 0.2% | — | |
| — | RVMDverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | REVOLUTION MEDICINES INC REVOLUTION MEDICINES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $4.9M | 50,000 | — | 0.2% | — | |
| — | — | NOODLES & CO NOODLES & CO · CL A NEW CUSIP 65540B303 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $4.7M | 553,746 | — | 0.2% | — | |
| — | — | INHIBIKASE THERAPEUTICS INC INHIBIKASE THERAPEUTICS INC · COM NEW CUSIP 45719W205 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $4.5M | 2,701,863 | — | 0.2% | — | |
| — | — | MARA HOLDINGS INC MARA HOLDINGS INC · NOTE 3/0 CUSIP 565788AF3 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $4.4M | 5,000,000 PRN | — | 0.2% | — | |
| — | IRONverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DISC MEDICINE INC | $4.3M | 66,653 | — | 0.2% | — | |
| — | CZRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CAESARS ENTERTAINMENT INC NE CAESARS ENTERTAINMENT INC NE · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $4.0M | 150,000 | — | 0.1% | — | |
| — | — | FORRESTER RESH INC FORRESTER RESH INC · COM CUSIP 346563109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $3.9M | 694,422 | — | 0.1% | — | |
| — | — | THE ONE GROUP HOSPITALITY IN THE ONE GROUP HOSPITALITY IN · COM CUSIP 88338K103 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $3.8M | 2,121,084 | — | 0.1% | — | |
| — | — | TELA BIO INC | $3.7M | 5,894,114 | — | 0.1% | — |
1–100 of 135 issuers · page 1 of 2
every row this filer reported for the quarter, as it reported it — cross-filer de-duplication is applied to issuer totals elsewhere and never deletes a row here
A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗
13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.
Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.
Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.
Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.
Positions under confidential treatment may be omitted until a later amendment discloses them.
These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).